RhumbLine Advisers
BDTX icon

RhumbLine Advisers’s Black Diamond Therapeutics BDTX Stock Holding History

RhumbLine Advisers’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.1K Buy
+36,795
New +$90K ﹤0.01% 3630
2025
Q2 		– Sell
-54,836
Closed -$85K – 4151
2025
Q1 		$85K Sell
54,836
-1,299
-2% -$2.72K ﹤0.01% 3446
2024
Q4 		$120K Buy
56,135
+7,290
+15% +$20.9K ﹤0.01% 3422
2024
Q3 		$212K Buy
48,845
+1,995
+4% +$10.9K ﹤0.01% 3209
2024
Q2 		$218K Buy
46,850
+46,401
+10,334% +$249K ﹤0.01% 3178
2024
Q1 		$2.28K Hold
449
– – ﹤0.01% 4079
2023
Q4 		$1.26K Hold
449
– – ﹤0.01% 4136
2023
Q3 		$1.29K Hold
449
– – ﹤0.01% 4160
2023
Q2 		$2.27K Buy
+449
New +$917 ﹤0.01% 4200
2022
Q2 		– Sell
-29,064
Closed -$81K – 3108
2022
Q1 		$81K Sell
29,064
-1,749
-6% -$6.39K ﹤0.01% 2926
2021
Q4 		$164K Sell
30,813
-580
-2% -$4.05K ﹤0.01% 2875
2021
Q3 		$266K Buy
31,393
+1,075
+4% +$10.6K ﹤0.01% 2811
2021
Q2 		$370K Buy
30,318
+12,012
+66% +$237K ﹤0.01% 2696
2021
Q1 		$444K Sell
18,306
-1,105
-6% -$29.8K ﹤0.01% 2544
2020
Q4 		$622K Buy
19,411
+2,392
+14% +$78.6K ﹤0.01% 2344
2020
Q3 		$514K Buy
17,019
+1,879
+12% +$57.2K ﹤0.01% 2279
2020
Q2 		$638K Buy
15,140
+3,079
+26% +$113K ﹤0.01% 2234
2020
Q1 		$301K Buy
+12,061
New +$367K ﹤0.01% 2401

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

RhumbLine Advisers's BDTX Position: Q2 2026 in Review

RhumbLine Advisers opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 36,795 shares worth $68.1K. The stake represents ﹤0.01% of the portfolio and ranks #3630 among its holdings. This is a return to the name: RhumbLine Advisers previously reported a position in BDTX as recently as Q1 2025.

RhumbLine Advisers first reported a position in BDTX in Q1 2020 and has held it in 18 quarters since. The position peaked at $638K in Q2 2020. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • RhumbLine Advisers held 36,795 shares of Black Diamond Therapeutics worth $68.1K as of Q2 2026.
  • Black Diamond Therapeutics was a new RhumbLine Advisers position in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3630 holding.
  • RhumbLine Advisers first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 18 quarters since.
  • RhumbLine Advisers's Black Diamond Therapeutics position peaked at $638K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.